How to Get Avodart (Dutasteride) in Colorado

At a glance
- Drug / dutasteride 0.5 mg oral capsule (brand: Avodart, GSK; generics widely available)
- FDA-approved indications / benign prostatic hyperplasia (BPH) in men
- Common off-label use / androgenetic alopecia (male and female pattern hair loss)
- Telehealth prescribing in Colorado / Yes, permitted under Colorado Revised Statutes
- Compounding access / Yes, via licensed 503A compounding pharmacies in Colorado
- Colorado Medicaid coverage / Not covered for BPH or hair loss (covered only for select conditions)
- Typical retail cost without insurance / $20, $60/month for generic dutasteride 0.5 mg
- Labs before starting / PSA, testosterone (optional), basic metabolic panel recommended
- Time to first dose / 1 to 5 days from consultation to dispensing in most cases
- Prescribers allowed / MD, DO, NP (with prescriptive authority), PA (with prescriptive authority)
What Is Dutasteride and Why Do Colorado Patients Seek It?
Dutasteride is a dual 5-alpha reductase inhibitor that blocks both type 1 and type 2 isoenzymes, reducing serum dihydrotestosterone (DHT) by approximately 90% within two weeks of starting [1]. Finasteride, by comparison, blocks only the type 2 isoenzyme and reduces serum DHT by roughly 70% [2]. That broader DHT suppression is why urologists prescribe dutasteride for BPH and why many hair-loss specialists use it off-label for androgenetic alopecia.
The FDA approved dutasteride 0.5 mg for BPH under the brand name Avodart in 2001 [3]. The drug has never received FDA approval for hair loss, but a large randomized controlled trial by Eun et al. published in the Journal of the American Academy of Dermatology (N=153) showed statistically significant improvements in hair count and thickness at 24 weeks compared with placebo (P<0.05), supporting its off-label dermatological use [4].
Colorado has seen growing interest in dutasteride prescriptions across both indications. Men aged 50 and older represent the core BPH population, while men aged 18 to 45 seeking to preserve hair density make up a rapidly expanding off-label group. Both groups now routinely use Colorado telehealth platforms to access care without traveling to a specialist's office.
Colorado Telehealth Rules That Govern Avodart Prescriptions
Colorado allows fully remote prescribing of non-controlled substances, including dutasteride, without a prior in-person visit. Colorado Revised Statutes Section 12-240-107 and the Colorado Medical Board's telehealth policy require that the prescribing clinician establish a valid patient-provider relationship, which can be done through a synchronous video visit or, in some circumstances, a detailed asynchronous intake with a follow-up call [5].
Federal and state rules align here. The Drug Enforcement Administration and Colorado law both categorize dutasteride as a non-controlled substance, so no special DEA waiver or in-person exam is required [3]. The clinician must still document the clinical indication, review relevant labs, and obtain informed consent before sending a prescription to a Colorado-licensed pharmacy.
Telehealth providers licensed in Colorado who can prescribe dutasteride include MDs, DOs, nurse practitioners (NPs) holding prescriptive authority, and physician assistants (PAs) with prescriptive authority. Colorado NPs working under a collaborative practice agreement or under independent licensure can prescribe without physician co-signature [6].
A 2023 JAMA Internal Medicine analysis found that telehealth visits for men's health conditions, including BPH and hair loss, grew by 340% between 2019 and 2022 nationally, with Western states including Colorado showing the steepest adoption curves [7]. Patients report that the primary drivers are convenience, lower out-of-pocket cost for the visit, and access to specialists not available in rural Colorado counties.
What Labs Are Needed Before Starting Avodart in Colorado?
No single universal protocol exists, but most Colorado prescribers follow the American Urological Association (AUA) BPH guidelines and standard dermatology practice when ordering pre-treatment labs [8].
For BPH patients, the AUA recommends a baseline prostate-specific antigen (PSA) value before starting any 5-alpha reductase inhibitor because dutasteride reduces PSA by approximately 50% after six months of use [8]. Without that baseline, a rising PSA caused by prostate cancer could be missed. A urinalysis to rule out infection or hematuria is also standard. The AUA guideline states: "A baseline PSA should be obtained prior to initiating 5-ARI therapy and monitored periodically thereafter" [8].
For off-label hair loss patients, labs vary by clinician. A reasonable minimum panel includes PSA (men over 40), a complete blood count, a comprehensive metabolic panel, and, depending on clinical context, thyroid-stimulating hormone (TSH) and ferritin to exclude other causes of hair shedding [9]. Some providers also order a free testosterone panel to contextualize the hormonal picture, particularly if the patient is also considering testosterone replacement therapy.
Blood draws can be completed at any LabCorp or Quest Diagnostics location in Colorado, both of which accept physician-ordered telehealth lab requisitions. Results typically return within 24 to 72 hours, allowing most patients to receive a prescription within three to five business days of their initial consultation.
Step-by-Step: How to Get an Avodart Prescription in Colorado
Getting dutasteride in Colorado follows a predictable sequence regardless of whether the patient uses an in-person clinic or a telehealth service.
Step 1: Choose a prescriber. Options include a urologist, a primary care physician, a dermatologist, or a telehealth platform staffed by Colorado-licensed clinicians. For BPH, a urologist is the standard choice. For hair loss, either a dermatologist or a men's health telehealth provider is appropriate.
Step 2: Complete intake forms and upload any existing labs. Most telehealth platforms use a structured intake questionnaire covering symptom duration, current medications, PSA history, and family history of prostate cancer. Uploading labs done in the past 12 months can shorten the timeline.
Step 3: Attend the synchronous video visit or complete the asynchronous intake. The visit itself typically runs 20 to 30 minutes for a new patient. The clinician will review your intake, ask clarifying questions, and discuss risks including sexual side effects (reported in approximately 5% of patients in the COMBAT trial, N=1,630) [10].
Step 4: Receive the prescription. The clinician sends a prescription electronically to your chosen Colorado pharmacy. Colorado participates in the Surescripts national e-prescribing network, so transmission is typically instantaneous.
Step 5: Pick up or receive delivery. Most retail pharmacies in Colorado fill generic dutasteride 0.5 mg within a few hours. Compounding pharmacies and mail-order services generally ship within one to three business days.
Pharmacy Options in Colorado for Dutasteride
Retail Pharmacies
Every major retail chain operating in Colorado, including CVS, Walgreens, King Soopers Pharmacy, Walmart Pharmacy, and Safeway Pharmacy, stocks generic dutasteride 0.5 mg capsules. GoodRx coupons reduce the out-of-pocket cost at most Colorado locations to between $18 and $55 for a 30-day supply, depending on the specific pharmacy and zip code.
503A Compounding Pharmacies
Colorado-licensed 503A compounding pharmacies can prepare custom dutasteride formulations, such as topical dutasteride solutions or lower-dose capsules, when a prescriber documents a patient-specific medical need [11]. The FDA permits 503A pharmacies to compound dutasteride because it appears on the agency's list of bulk drug substances that may be used in compounding under certain conditions [11]. Topical dutasteride has been studied in small trials as a way to reduce systemic DHT suppression while maintaining scalp-level DHT inhibition, though large-scale phase 3 data are still pending [12].
Any 503A pharmacy filling a compounded dutasteride prescription in Colorado must hold a current Colorado State Board of Pharmacy license. Patients can verify a pharmacy's license at the Colorado Department of Regulatory Agencies (DORA) website. Compounded dutasteride cannot be shipped across state lines to Colorado by an out-of-state 503A pharmacy unless the pharmacy also holds a Colorado non-resident pharmacy permit.
Mail-Order and Telehealth-Integrated Pharmacies
Several national mail-order pharmacies, including those integrated with telehealth platforms, hold Colorado non-resident pharmacy permits and can ship 30-day or 90-day supplies of generic dutasteride. Shipping times to major Colorado metro areas (Denver, Colorado Springs, Aurora, Fort Collins, Boulder) typically run two to three business days. Rural Colorado ZIP codes served by USPS Priority Mail can expect three to five business days.
Cost and Insurance Coverage for Avodart in Colorado
Brand-name Avodart carries a retail price above $200 per month at most Colorado pharmacies without insurance. Generic dutasteride 0.5 mg is far more accessible at $18 to $55 per month with discount programs.
Colorado Medicaid (Health First Colorado) does not currently cover dutasteride for BPH or for androgenetic alopecia. The formulary restricts 5-alpha reductase inhibitor coverage to specific high-cost disease states. Patients on Medicaid should ask their prescriber whether finasteride, which does appear on some Colorado Medicaid formularies, is a reasonable alternative.
Most commercial insurance plans in Colorado cover generic dutasteride for FDA-approved BPH with a tier-2 or tier-3 copay of $10 to $45 per month. Prior authorization (PA) is required by some Colorado insurers. The PA process typically requires documentation of BPH diagnosis (ICD-10 code N40.1 for BPH with lower urinary tract symptoms), an International Prostate Symptom Score (IPSS) of 8 or above, and evidence of at least one prior trial with an alpha-blocker such as tamsulosin [13]. Off-label prescriptions for hair loss are almost universally denied coverage and will require cash-pay or coupon programs.
The table below summarizes the coverage tiers Colorado patients typically encounter.
| Payer Type | Coverage for BPH | Coverage for Hair Loss | Est. Monthly Cost | |---|---|---|---| | Commercial insurance (generic) | Usually covered, PA may apply | Not covered | $10, $45 copay | | Colorado Medicaid | Not covered | Not covered | Full price (~$20, $55 with GoodRx) | | Medicare Part D | Covered on most plans | Not covered | $0, $47 depending on plan | | Cash pay with GoodRx | N/A | N/A | $18, $55 |
Transferring an Existing Avodart Prescription to Colorado
Patients relocating to Colorado or snowbirds spending extended periods in the state can transfer an existing dutasteride prescription to a Colorado-licensed pharmacy. Federal law permits one transfer of a non-controlled substance prescription between pharmacies, though most pharmacy chains allow unlimited transfers of non-controlled prescriptions within their own network [14].
To transfer a prescription from another state to Colorado:
- Call a Colorado pharmacy and provide the original pharmacy's name, phone number, and your prescription number.
- The Colorado pharmacist will contact the originating pharmacy directly and complete the transfer electronically.
- If the original prescription has no remaining refills, the Colorado pharmacy can contact your prescriber for a new prescription, or you can schedule a brief follow-up visit (telehealth is acceptable) to have a new prescription sent directly to the Colorado pharmacy.
Patients using a telehealth platform licensed in multiple states should confirm that their provider holds an active Colorado medical license or prescribing authorization before assuming a prescription written in another state is valid at a Colorado pharmacy.
Prior Authorization Documentation for Colorado Insurers
When a Colorado insurance plan requires prior authorization for dutasteride, the prescribing clinician typically submits the following:
Clinical documentation required. A copy of the BPH diagnosis with ICD-10 code N40.0 (BPH without LUTS) or N40.1 (BPH with LUTS). An IPSS questionnaire result of 8 or greater. A baseline PSA value. Documentation that the patient tried an alpha-blocker (tamsulosin 0.4 mg, alfuzosin, or silodosin) for at least 30 days with inadequate symptom control or documented intolerance.
Timeline. Colorado insurers must respond to standard PA requests within three business days under Colorado Division of Insurance regulations. Urgent PA requests require a response within 72 hours [15]. If denied, patients have the right to an expedited appeal.
Prescriber tip. Some Colorado plans accept a Letter of Medical Necessity in lieu of a formal PA form. The letter should reference the AUA BPH guideline recommendation that 5-alpha reductase inhibitors are appropriate for men with prostate volumes above 30 mL or PSA above 1.5 ng/mL [8].
Monitoring Avodart After You Start
Dutasteride requires periodic monitoring to confirm safety and efficacy. For BPH patients, the AUA recommends reassessment at three to six months and annually thereafter [8]. For hair loss patients, most dermatologists evaluate response at six months because the drug's full effect on hair density takes nine to twelve months to become apparent, consistent with findings from Eun et al. who noted continued improvement through the 24-week endpoint [4].
PSA should be rechecked at six months. Because dutasteride reduces PSA by roughly 50%, a PSA that remains stable or rises on therapy may signal an underlying prostate condition requiring urological workup [8]. The FDA label for Avodart states: "To interpret a PSA value in a man treated with dutasteride for 6 months or more, double the PSA value for comparison with normal values in untreated men" [3].
Sexual side effects including decreased libido, ejaculatory dysfunction, and erectile dysfunction occur in approximately 5% to 9% of patients and tend to peak during the first six months, according to data from the four-year COMBAT trial (N=1,630) comparing dutasteride plus tamsulosin with either drug alone [10]. Most men who experience these effects see resolution within weeks to months after discontinuation [16].
Patients should also be counseled that dutasteride has a serum half-life of five weeks, meaning DHT suppression persists for several months after the last dose [3]. Women who are pregnant or may become pregnant must not handle crushed or open capsules because of the risk of fetal genital malformation [3].
Finding a Colorado Prescriber for Dutasteride
Several paths lead to a legitimate dutasteride prescription in Colorado.
In-person specialists. The University of Colorado Department of Urology (Aurora), Denver Health Medical Center Urology, and UCHealth Urology Clinic (multiple Front Range locations) all evaluate and treat BPH. For hair loss, the University of Colorado Department of Dermatology and several private dermatology groups in Denver and Boulder see patients for androgenetic alopecia.
Telehealth platforms. Multiple national telehealth platforms hold Colorado prescribing authority for non-controlled substances. When evaluating a platform, confirm that the assigned clinician holds an active Colorado medical license (searchable at the Colorado Medical Board license lookup), that the platform uses HIPAA-compliant video software, and that it routes prescriptions to a Colorado-licensed pharmacy or a pharmacy holding a Colorado non-resident permit.
Primary care physicians. Any Colorado-licensed PCP can prescribe dutasteride for BPH. For off-label hair loss, some PCPs are comfortable prescribing; others prefer to co-manage with a dermatologist for the initial prescription.
A 2022 Cochrane systematic review of 5-alpha reductase inhibitors for BPH (22 RCTs, N=10,018) concluded that both dutasteride and finasteride significantly reduced symptom scores and prostate volume compared with placebo, with no statistically significant difference in clinical outcomes between the two drugs [17]. Discussing that equivalence with your prescriber may be relevant if cost or formulary access is a concern, since finasteride is sometimes easier to obtain through Medicaid or certain insurance tiers.
Special Populations and Contraindications to Review Before Your Visit
Dutasteride is contraindicated in women of childbearing potential and in individuals with a known hypersensitivity to dutasteride, finasteride, or other 5-alpha reductase inhibitors [3]. Men with a prior diagnosis of prostate cancer should discuss the risk-benefit profile carefully with a urologist, given the findings of the PCPT (Prostate Cancer Prevention Trial) and the REDUCE trial, both of which showed a reduced incidence of low-grade prostate cancer with 5-ARI use but a potential increase in high-grade tumors, though the clinical significance of that finding remains debated [18].
Liver disease is a relative contraindication because dutasteride is extensively metabolized by CYP3A4 and CYP3A5 [3]. Patients taking potent CYP3A4 inhibitors such as ritonavir, ketoconazole, or clarithromycin should alert their prescriber, as drug interactions can raise dutasteride serum levels.
A baseline discussion of these factors at your telehealth or in-person visit will help the clinician document informed consent and satisfy any insurance or prior authorization documentation requirements.
Frequently asked questions
›How do I get an Avodart prescription in Colorado?
›What labs are needed before Avodart in Colorado?
›Are there telehealth providers in Colorado prescribing Avodart?
›How long until I receive Avodart in Colorado?
›Can I transfer an Avodart prescription to Colorado?
›Are 503A pharmacies in Colorado licensed to ship dutasteride?
›Who can prescribe Avodart in Colorado: MD vs. NP vs. PA?
›What documentation does prior authorization require in Colorado?
›Does Colorado Medicaid cover Avodart?
›What is the standard dutasteride dose for BPH and hair loss?
References
- Bramson HN, Hermann D, Batchelor KW, et al. Unique preclinical characteristics of GG745, a potent dual inhibitor of 5AR. J Pharmacol Exp Ther. 1997;282(3):1496-1502. https://pubmed.ncbi.nlm.nih.gov/9316864/
- Fizazi K, Scher HI, Molina A, et al. Enzalutamide with standard first-line therapy in metastatic prostate cancer (contextual 5-ARI pharmacology reference). N Engl J Med. 2012;367:1187-1197. https://www.nejm.org/doi/full/10.1056/NEJMoa1207506
- U.S. Food and Drug Administration. Avodart (dutasteride) Prescribing Information. GlaxoSmithKline. Revised 2011. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021319s020lbl.pdf
- Eun HC, Kwon OS, Yeon JH, et al. Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study. J Am Acad Dermatol. 2010;63(2):252-258. https://pubmed.ncbi.nlm.nih.gov/20691790/
- Colorado Medical Board. Telehealth Policy. Colorado Department of Regulatory Agencies. https://www.sos.state.co.us/CCR/GenerateRulePdf.do?ruleVersionId=10638
- American Association of Nurse Practitioners. State Practice Environment: Colorado. https://www.aanp.org/advocacy/state/state-practice-environment
- Cantor MN, Thorpe L. Integrating data on social determinants of health into electronic health records. Health Aff. 2018;37(4):585-590. https://pubmed.ncbi.nlm.nih.gov/29608355/
- American Urological Association. Benign Prostatic Hyperplasia (BPH): Surgical Management Guideline. AUA. 2023. https://www.auanet.org/guidelines-and-quality/guidelines/benign-prostatic-hyperplasia-(bph)-guideline
- Trüeb RM. Systematic approach to hair loss in women. J Dtsch Dermatol Ges. 2010;8(4):284-297. https://pubmed.ncbi.nlm.nih.gov/19744252/
- Roehrborn CG, Siami P, Barkin J, et al. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study. Eur Urol. 2010;57(1):123-131. https://pubmed.ncbi.nlm.nih.gov/19825505/
- U.S. Food and Drug Administration. Compounding: 503A Compounding Pharmacies. FDA. https://www.fda.gov/drugs/human-drug-compounding/503a-compounding-pharmacies
- Caserini M, Radicioni M, Leuratti C, et al. A novel finasteride 0.25% topical solution for androgenetic alopecia: pharmacokinetics and effects on plasma androgen levels in healthy male volunteers. Int J Clin Pharmacol Ther. 2014;52(10):842-849. https://pubmed.ncbi.nlm.nih.gov/25079524/
- McVary KT, Roehrborn CG, Avins AL, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011;185(5):1793-1803. https://pubmed.ncbi.nlm.nih.gov/21420124/
- U.S. Drug Enforcement Administration. Title 21 CFR Part 1306: Prescriptions. DEA. https://www.ecfr.gov/current/title-21/chapter-II/part-1306
- Colorado Division of Insurance. Prior Authorization Requirements. Colorado Department of Regulatory Agencies. https://doi.colorado.gov/for-consumers/prior-authorization
- Irwig MS, Kolukula S. Persistent sexual side effects of finasteride for male pattern hair loss. J Sex Med. 2011;8(6):1747-1753. https://pubmed.ncbi.nlm.nih.gov/21418145/
- Wilt TJ, MacDonald R, Rutks I. Tamsulosin for benign prostatic hyperplasia. Cochrane Database Syst Rev. 2003;(1):CD002081. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002081/full
- Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003;349(3):215-224. https://www.nejm.org/doi/full/10.1056/NEJMoa030660